Abel Hall LLC’s Disc Medicine IRON Stock Holding History

Abel Hall LLC’s Portfolio IRON Stock Details IRON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-4,443	Closed	-$353K	–	898
2025 Q4	$353K	Buy	+4,443	New	+$375K	0.08%	267

Other funds holding IRON

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Abel Hall LLC's IRON Position: Q1 2026 in Review

Abel Hall LLC sold out of Disc Medicine (IRON) in Q1 2026, closing a stake of 4,443 shares — an estimated $353K sold.

Abel Hall LLC first reported a position in IRON in Q4 2025 and held it in 1 quarter. The position peaked at $353K in Q4 2025. 203 funds tracked by Wall St. Rank hold IRON as of Q1 2026.

Abel Hall LLC reported no remaining Disc Medicine position as of Q1 2026 after selling out during the quarter.
Abel Hall LLC sold 4,443 Disc Medicine shares in Q1 2026, an estimated $353K.
Abel Hall LLC first reported a position in Disc Medicine in Q4 2025 and held it in 1 quarter.
Abel Hall LLC's Disc Medicine position peaked at $353K in Q4 2025.
203 funds tracked by Wall St. Rank held Disc Medicine as of Q1 2026.

Based on Abel Hall LLC's 13F filing for Q1 2026, filed 28 Apr 2026.